chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient was hospitalized after receiving the GARDASIL 9 vaccination; Information has been received from a consumer referring to a 11-year-old male patient via a vaccine representative. The patient's pertinent medical history, concurrent condition and concomitant therapy were not reported.    On an unknown date, the patient was vaccinated with HPV rl1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (strength, dose, frequency, route, lot # and expiration date were not reported) for prophylaxis.         The reporter, as the patient's aunt, reported that the patient was hospitalized after receiving the HPV rl1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9). The outcome of the hospitalization was unknown.  The reporter did not provide causal relationship between the hospitalization and the vaccine.
410PM LPE complete immunization given (DTAP IPV MMR Varicella) 415P child started cough. 4:20pm wheeze A-P lungs. Benadryl 12.5mg / 5ml Sig 15 ml given. 4:25pm epinephrine 1:1000 0.3ml given SQ (wt 62 pounds). 911 called - Ambulance transported to ER @ 5:00 pm at time of transport lungs CTA. Hives R arm to wrist.
swelling, tenderness of L thigh.  Febrile Xray--showed soft tissue swelling labs showed elevated WBC & CRP hip MRI showed myositis ABT for treatment.  IV Ancef and Augmentin per GTube.
Body aches, "flu-like", but no fever from 11:00 pm to AM. Nausea from 9/16/04 AM until 9 PM.
She got her vaccine, she had what felt like an arrhythmia, palpitations and having problems with her rhythm, skipping beats and trying to get back on track.  It was scary, she was afraid to go to sleep that night.  She was doing breathing exercises and everything she read to do while watching You-Tube  She laid on her right side.  She was going to go to the hospital if it continued the next day.  It went on until 1:00 or 2:00 AM when it felt like her heart was back in rhythm.  It felt like electrical activity in her heart.  She has had palpitations in the past and has felt her heart skipping beats in the past.   She did not have any issues other than a little bit of pain at the injection site, which was not tender until she touched it.   The feeling has gone away.     She did get a fever with her previous vaccines but they did not last long, and no fever or feeling sick with this vaccine, just the issues with her heart.
Info has been received from a health professional concerning a male employee in his 20's with no known medical history who on 3/14/05 was vaccinated with a 1st dose of varicella virus vaccine live. There was no concomitant medication. On 3/28/05, two weeks post/vax, the pt experienced a headache and developed a fever of 99.9F. On 3/29/05, the pt developed 4 bumps. It was reported that "the bumps did not look like normal chickenpox and never drained or became a vesicle". The pt still experiences headaches upon awaking. The pt's bumps never completely resolved. It was reported that the injection site was fine with no marks, redness or pain in the arm. At the time of the report the pt had not yet recovered. Unspecified medical attention was sought. There was no product quality complaint involved. Additional info has been requested.
Expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
PAIN FROM WRIST TO FINGER; NUMBNESS FROM LEFT WRIST TO FINGER; This spontaneous report received from a patient concerned a 64 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, unknown route and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the patient experienced numbness from left wrist to finger. On 12-APR-2021, the patient experienced pain from wrist to finger. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from numbness from left wrist to finger, and pain from wrist to finger. This report was non-serious.
Within 48 hours my blood pressure, which was under control, shot up to 210/124. I immediately went to my physician's office.
On day 8 after the initial immunization, a large erythematous itchy patch appeared on the left arm at the injection site.  Symptoms of redness and itching persisted for 6 more days.
After receiving the second shot I've had a content headache that will not go away even with any over the counter medication. I've also been extremely tired/sleepy and my body has been weak. It's been two weeks since my shot and feeling like this., the symptoms haven't gone away.
soreness in arm; headache; slight fever; pain in arm which travelled from top of arm to tips of her fingers; pain in her chest (left chest/breast area); could not lay down on her left or right side; chest pain was really bad; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain in arm which travelled from top of arm to tips of her fingers), CHEST PAIN (pain in her chest (left chest/breast area)), PAIN IN EXTREMITY (could not lay down on her left or right side), CHEST PAIN (chest pain was really bad) and PAIN IN EXTREMITY (soreness in arm) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PAIN (pain in arm which travelled from top of arm to tips of her fingers), CHEST PAIN (pain in her chest (left chest/breast area)), PAIN IN EXTREMITY (could not lay down on her left or right side), CHEST PAIN (chest pain was really bad) and PYREXIA (slight fever). On 11-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm) and HEADACHE (headache). The patient was treated with IBUPROFEN at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (pain in arm which travelled from top of arm to tips of her fingers), CHEST PAIN (pain in her chest (left chest/breast area)), PAIN IN EXTREMITY (could not lay down on her left or right side), CHEST PAIN (chest pain was really bad), PAIN IN EXTREMITY (soreness in arm), PYREXIA (slight fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment with Ibuprofen and Tylenol were provided.
redness and swelling at site of injection immediately after injecting, approx. 4 cm area of redness, 1 cm area of swelling centerally
BAD SYMPTOMS; HIGH FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be  requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced bad symptoms, and high fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) High. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the high fever and bad symptoms was not reported. This report was non-serious.
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ (lot # M004890, expiration date 11-OCT-2017; lot # L035511, expiration date 21-MAY-2017; lot # L033694, expiration date 16-JUL-2017; lot # L027719, expiration date 28-APR-2017; dose not reported) orally. The doses of vaccine were improperly stored at 60 degree Fahrenheit for 25 minutes. Data logger was involved. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Hives on arms, legs, and torso. Red, warm, swelling around area where shot was given. Fever
Woke up with double vision in right eye.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 08Apr2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and nortriptyline (MANUFACTURER UNKNOWN); both for unknown indication and start date. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Apr2021 at 10:00, the patient woke up with double vision in right eye. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event woke up with double vision in right eye was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
10 years old COVID 19 gray cap .3 ml FM7553; Headache; Sore arm; This is a spontaneous report received from contactable reporter(s) (Nurse) from a sales representative.  A 10-year-old male patient received BNT162b2 (BNT162B2), on 15Jun2022 as dose 3 (booster), 0.3 ml single (Lot number: FM7553) at the age of 10 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1, Anatomical site of injection; Left arm, Route of administration: Intramuscular, Batch/Lot number: FK5127), administration date: 14Nov2021, for COVID-19 Immunization; BNT162b2 (Dose: 2, Anatomical site of injection; Right arm, Batch/Lot number: FL8095), administration date: 02Jan2022, for COVID-19 Immunization, reaction(s): "Inappropriate schedule of vaccine administered"; fluzone (Manufacturer: Sanofi, Batch/Lot number: 4T73378K, Route: Intramuscular, Anatomical site of injection: Right arm, No. of previous doses: 10), administration date: 27Oct2021, for COVID-19 Immunization. The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious) with onset 15Jun2022, outcome "unknown", described as "10 years old COVID 19 gray cap .3 ml FM7553"; HEADACHE (non-serious) with onset 2022, outcome "recovering"; PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "recovering", described as "Sore arm".  Additional information: It was reported that the patient's weight was 99.2 pounds. No underlying conditions. Event did not take place after use of the product. Patient did not provide information regarding the reported adverse event with the use of the product. Patient received 12 and older Pfizer COVID vaccine. After vaccination, soon had a headache and sore arm which were not major. Overall he was fine. Specific relevant test: For thromboembolic events with thrombocytopenia was None.  Follow-up (27Jul2022): This is a spontaneous follow-up report from a contactable other HCP. This other HCP reported in response to HCP letter [sent to other HCP] via follow-up letter which included that: Updated information included: Reporter details was updated and New reporters, Historical vaccine (vaccine administration date, anatomical site of injection, route of administration, batch/Lot number), Vaccination details RMH and New events (headache and sore arm) was added.
Headache; Pain in the arm; she has trouble with pain in her knees; Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 52-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EJ1685), via an unspecified route of administration, administered in left arm on an unspecified date as dose 2, single for covid-19 immunization. The patient medical history included thyroid (hypo). The patient concomitant medications included vitamin D3, ascorbic acid (VITAMIN C), tocopherol (VITAMIN E); all started an year ago. The patient had not received any other vaccine within 4 weeks. The patient had previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization and experienced stomach upset. On an unknown date, the patient experienced pain in the arm, she have good and bad side effects, first of all she has trouble with pain in her knees and today she relieved from much pain in knees, headache, diarrhea. The patient was treated with Ibuprofen 40mg for headache. The patient was not visited to emergency room/ physician office, Relevant tests were none. No predisposing factors was found. No culture was performed. No use of specify antipyretic use. The outcome of the event pain in the arm was unknown and the other events was recovered on an unspecified date.   No follow-up attempts are needed. No further information is expected.
This report was received from the investigator on 20 May 2010. A 27 year-old male subject received the following vaccines on 27 October 2009: ACAM2000 (lot number not reported); typhoid Vi CPS (sanofi pasteur, lot number not reported), anthrax (manufacturer and lot number not reported) and Japanese Encephalitis (manufacturer and lot number not reported). The subject was vaccinated with influenza, LIVE intranasal (manufacturer and lot number not reported) three weeks prior. Six days after smallpox vaccination on 02 November 2009, the subject was diagnosed with acute pericarditis unspecified. The subject had an abnormal electrocardiogram on 02 November 2009 and had a normal troponin I test on 13 November 2009. No other information was provided. Additional information will be requested from the investigator. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study.
On Tuesday, October 20 I was picking up prescriptions at the drive-through pharmacy listed above in this report. I asked if  the new Novavax  Covid vaccine was available and I was told that it was. I asked the pharmacy tech at the drive-through window again to verify that they had Novavax because I had been checking daily and it didn't show online as available. She assured me that they had it.  I parked and went inside the store to do a walk-in vaccination. I asked three other techs that I encountered while signing up if the vaccine they were going to give me was, in fact, the new Novavax. One of the techs even told me that they had just gotten it. Right before one of the techs was about to vaccinate me, I asked AGAIN for her to verify that the vaccine that I would be getting was Novavax. She assured me that it was and proceeded to vaccinate me. I received no paperwork except a sticker on my Covid card. I went home and told my husband that pharmacy had the new Novavax and he went to the store to get his vaccine. Like me, he asked no less than 4 techs to verify that he would be getting the new Novavax and he was told the same thing that I had been told. He was actually given paperwork. About an hour or so after he arrived home, he showed me the paperwork because he said he had read it and it said it was Comirnaty by Pfizer and an MRNA vaccine. He was shocked, as was I. I checked my sticker and saw that it was the same! I immediately called the pharmacy and insisted on talking to a pharmacist. I told her the story and she said that they did not have any Novavax. She seemed shocked to hear that so many employees had told my husband and me that we were receiving the Novavax. She apologized, but I asked what I could expect them to do about this. My doctor had recommended a few weeks ago that I wait for the Novavax shot for my latest booster. Pharmacist had no idea if or when I could be re-vaccinated. I also asked who would pay for the re-vaccination since I suspected none of my insurance providers would do so.  While I did not have a typical "adverse event," I was given an MRNA shot that I did not expect or request.
3-days post vaccine, experienced hearing loss in left ear. Got dizzy and vomiting. Couldn't stand or walk. Admitted to the hospital for 4-days.
She said her lip swelling has gotten worse since her first COVID-19 Vaccine dose in Jan2021; had some dry lips; cracked lips; This is a spontaneous report from a contactable consumer or other non hcp (patient) via medical information team. A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection; #lot Number: EL1283) intramuscularly, administered in left arm on 21Jan2021 (at the age of 67-years-old) as single dose for covid-19 immunisation. The patient's medical history included that she had an issue with her lips swelling since she started wearing a face mask in Mar2020 and historical vaccine included she had her annual flu shot in either last Oct2020 or Nov2020. Patient reported that she started a low carb diet at the end of Dec2020 or beginning of Jan2021. She said her low carb diet is medically controlled by a doctor and also reported she keeps rinsing her mouth with warm salt water. She said she has been rinsing her mouth with warm salt water since Jan2021 for altered taste. The patient's concomitant medications were not reported. On unspecified date in Jan2021, the patient had some dry, cracked lips and stated her lip swelling has gotten worse since her first covid-19 vaccine dose in jan2021. Therapeutic measures were taken as a result of her lip swelling has gotten worse since her first covid-19 vaccine dose in jan2021. Patient had taken Benadryl 25 mg tablet (#lot: KGL002; Expiration Date: Jun2022; NDC#: 50580-226-50) for her lip swelling treatment. The outcome of the event lip swelling has gotten worse was not recovered and the outcome of the remaining events was unknown.  Follow-up attempts completed. No further information expected.
Headaches, fevers/chills, muscle aches, unable to get out of bed. Unable to use right arm where injection given, injection site hurting a lot.
Tested positive for SARS-CoV-2 after being fully vaccinated with mRNA vaccine
Metallic taste in mouth, mild fatigue, mild nausea, injection site tenderness, sore left arm.
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 16-OCT-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L018499; expiry: 25-FEB-2017, (dose, route and frequency unspecified). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
HE FAINTED AFTER ONE MINUTE FROM COVID VACCINATION; THANKFULLY, HIS PARENTS WERE WITH HIM. I ASKED HIM IF HE WAS OK. HE CAME BACK RIGHT AWAY. I GAVE HIM WATER. CALLED THE FIRST ASSISTANT FROM THE STORE. A MANGER ASKED PARENTS IF HE NEEDED ER SERVICE. THEY REFUSED THE SERVICE BECAUSE HE REGAINED HIMSELF WELL. WE WILL FOLLOW UP TOMORROW TO MAKE SURE HE IS OK.
Severe chest pain and heartburn two days after injection. Fever which had been normal the first two shots. It's been a month with chest pain and I'm now on 40MG of omeprazole despite never having any stomach or heartburn issues my whole life. This has been on constant pain since day two of my injection. Last doctor appointment showed blood pressure around 120 and new reading after visiting the doctor is 140-160. This is despite me loosing close to 15lbs as of last year.
On the 15th I ended up in the ER because of this pain in my chest and neck. I could not do anything to alleviate the pain other than Nitro pills. The tests they ran showed the blood was not pumping through the bottom portion on my heart correctly. We did surgery which was a heart catherization and I was in the hospital for three days for this event.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). The patient was treated with NAPROXEN (MOTRIN [NAPROXEN]) for Headache, at a dose of 300 mg; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and DOXYCYCLINE HYCLATE on 20-Apr-2021 at a dose of 100 mg. At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information includes Used a cold bag of frozen Vegetable in injection site.   This case was linked to MOD21-071824, MOD21-071883, MOD21-080612 (E2B Linked Report). This case was linked to MOD-2021-086105 (Patient Link).; Sender's Comments:  MOD21-071824: MOD21-071883: MOD21-080612:
pt recv vax 7MAY96 & 29MAY96 pt exp itching;By 31MAY96 pt devel a full-blown chickenpox w/wide spread lesions on torso, face & abd;
This spontaneous report as received from a medical assistant refers to a 64 year old female patient. On 29-OCT-2014, the patient was vaccinated with an expired dose of ZOSTAVAX (lot # J007208 exp 20-SEP-2014) (dose, route and lot # not reported). No adverse effects were reported. Additional information has been requested.